Dr. Pnina Fishman is the scientific founder of Can-Fite BioPharma and was previously a professor of Life Sciences at the Bar-Ilan University in Israel and Headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or co-authored over 200 publications and presented the findings of her research at many major scientific meetings. Dr. Fishman is a world leader in the research of adenosine receptors and her scientific work is focused on the development of small molecule drugs which target the A3 adenosine receptor. This scientific work has gained recognition as one of the leading approaches for new generation therapies for liver diseases.